Aspirin and heparin in recurrent pregnancy loss treatment
Not Applicable
- Conditions
- recurrent pregnancy loss.Spontaneous abortion
- Registration Number
- IRCT2013102315123N1
- Lead Sponsor
- Research and Clinical Center for Infertility,Yazd, Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 252
Inclusion Criteria
unexplained recurrent pregnancy loss; women with thrombophilia exclusion criteria: abnormal karyotypes of each partner; uterine; cervical anatomical disorders on pelvic ultrasonography; hysteroscopy; abnormal ovaries function; abnormal endocrine tests; and antiphospholipid syndrome
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy after 20 weeks. Timepoint: after 20 weeks. Method of measurement: Sonography.
- Secondary Outcome Measures
Name Time Method ive-birth rates. Timepoint: 2 weeks after intervention. Method of measurement: mesearment of blood beta hCG.